Trial
NCT04520607
A Long-Term Safety and Efficacy Study of Lorecivivint in Subjects With Osteoarthritis of the Knee
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Biosplice Therapeutics, Inc.
Collaborators
—
Condition
Osteoarthritis, Knee
Intervention
Placebo
Why stopped
Study OA-07 was designed to be conducted until the Sponsor closed it. Study OA-07 was administratively closed at Visit 6E (Week 100), with no safety concerns, one year into the open-label study as described in the protocol.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-24